X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
apoptosis (9) 9
oncology (7) 7
protein kinase inhibitors - pharmacology (7) 7
animals (6) 6
cancer (6) 6
proto-oncogene proteins c-pim-1 - antagonists & inhibitors (6) 6
biochemistry & molecular biology (5) 5
kinases (5) 5
leukemia (5) 5
life sciences (5) 5
lymphomas (5) 5
phosphorylation (5) 5
pim kinases (5) 5
activation (4) 4
c-myc (4) 4
expression (4) 4
growth (4) 4
hemic and lymphatic diseases (4) 4
phosphotransferases (4) 4
pim-1 (4) 4
proteins (4) 4
proto-oncogene proteins c-pim-1 - metabolism (4) 4
serine/threonine kinases (4) 4
antineoplastic agents - pharmacology (3) 3
casein kinase ii - antagonists & inhibitors (3) 3
casein kinase ii - metabolism (3) 3
cell biology (3) 3
cell cycle (3) 3
cell line (3) 3
cell line, tumor (3) 3
cell proliferation - drug effects (3) 3
drug design (3) 3
gene expression (3) 3
hematology (3) 3
kinase (3) 3
kinetics (3) 3
molecular biology (3) 3
mtor (3) 3
original (3) 3
original articles (3) 3
pim kinase (3) 3
pim‐1 (3) 3
protein kinase inhibitors - chemistry (3) 3
protein-serine-threonine kinases - metabolism (3) 3
proto-oncogene proteins - metabolism (3) 3
rats (3) 3
rodents (3) 3
transgenic mice (3) 3
4,5,6,7-tetrabromobenzotriazole (2) 2
acid (2) 2
analysis (2) 2
apoptosis - drug effects (2) 2
binding sites (2) 2
biochemistry, general (2) 2
biomarker (2) 2
care and treatment (2) 2
casein kinase ii - genetics (2) 2
cell proliferation (2) 2
cell survival (2) 2
cell-cycle progression (2) 2
chronic lymphocytic-leukemia (2) 2
crystallography, x-ray (2) 2
depolarization (2) 2
e-mu-myc (2) 2
genes (2) 2
health aspects (2) 2
identification (2) 2
in-vivo (2) 2
indazoles - pharmacology (2) 2
inhibitor (2) 2
jurkat cells (2) 2
kinase inhibitors (2) 2
life sciences, general (2) 2
mice (2) 2
oncogene (2) 2
pharmacology & pharmacy (2) 2
phase-i (2) 2
phosphorylates bad (2) 2
pi3k (2) 2
pim kinase inhibitor (2) 2
potent (2) 2
protein (2) 2
protein-serine-threonine kinases - genetics (2) 2
proto-oncogene proteins - genetics (2) 2
provirus integration site for moloney murine leukaemia virus 1 (2) 2
pyridazines - pharmacology (2) 2
recombinant proteins - antagonists & inhibitors (2) 2
sgi-1776 (2) 2
site (2) 2
specificity (2) 2
structural basis (2) 2
structure-activity relationship (2) 2
substrate recognition (2) 2
survival (2) 2
target (2) 2
tumors (2) 2
60 applied life sciences (1) 1
abt-199 (1) 1
acute myeloid-leukemia (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical journal, ISSN 0264-6021, 08/2009, Volume 421, Issue 3, pp. 387 - 395
Journal Article
Biochemical journal, ISSN 1470-8728, 2007, Volume 408, Issue 3, pp. 297 - 315
The specificities of 65 compounds reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.... 
Drug discovery | Kinase profiling | Protein kinase | Anti-cancer drugs | Inhibitor specificity | RHO-ASSOCIATED KINASE | TUMOR PROGRESSION | FAMILY-MEMBERS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL-PROLIFERATION | protein kinase | P38 MAP KINASE | CYCLIN-DEPENDENT KINASES | RECEPTOR TYROSINE KINASES | drug discovery | kinase profiling | SB 203580 | anti-cancer drugs | ISOFORMS IN-VITRO | P90 RSK | inhibitor specificity | Amino Acid Sequence | Cell Line | Phosphorylation | Recombinant Proteins - antagonists & inhibitors | Animals | Mitogen-Activated Protein Kinases - antagonists & inhibitors | Humans | Drug Design | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | Mitogen-Activated Protein Kinases - metabolism | Spodoptera | Yes1, Yamaguchi sarcoma viral oncogene homologue 1 | CSK, C-terminal Src kinase | Lck, lymphocyte cell-specific protein-tyrosine kinase | EGF, epidermal growth factor | FGF-R, fibroblast-growth-factor receptor | PAK, p21-activated protein kinase | PDK, 3-phosphoinositide-dependent protein kinase | PI3K, phosphatidylinositol (phosphoinositide) 3-kinase | NEK, NIMA (never in mitosis in Aspergillus nidulans)-related kinase | RSK, p90 ribosomal S6 kinase | HEK-293 cells, human embryonic kidney-293 cells | VEGF, vascular endothelial growth factor (vasoendothelial growth factor) | EF2K, elongation-factor-2 kinase | CK, casein kinase | PTEN, phosphatase and tensin homologue deleted on chromosome 10 | ERK, extracellular-signal-regulated kinase | ATM, ataxia telangiectasia mutated | SRPK, serine-arginine protein kinase | IL-1, interleukin 1 | MNK, MAPK-integrating protein kinase | ROCK, Rho-dependent protein kinase | CaMKK, CaMK kinase | GST, glutathione transferase | MKK1, MAPK kinase-1 (also called MEK1, MAPK or ERK kinase 1) | GAK, cyclin G-associated kinase | FMK, fluoromethylketone | MST, mammalian homologue Ste20-like kinase | PKA, cAMP-dependent protein kinase | FKBP, FK506-binding protein | PPAR, peroxisome-proliferator-activated receptor | IKK, inhibitory κB kinase | PH, pleckstrin homology | MBP, myelin basic protein | AICAR, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside | MAPKAP-K, MAPK-activated protein kinase | Sf21, Spodoptera frugiperda (fall armyworm) 21 | MARK, microtubule-affinity-regulating kinase | PIM, provirus integration site for Moloney murine leukaemia virus | LPS, lipopolysaccharide | MSK, mitogen- and stress-activated protein kinase | MAPK, mitogen-activated protein kinase | MELK, maternal embryonic leucine-zipper kinase | His6, hexahistidine | CAK, cyclin-dependent kinase-activating kinase | Eph-A2, Ephrin A2 receptor | PLK, polo-like kinase | ATF2, activating transcription factor 2 | PKD, protein kinase D | Src, sarcoma kinase | AMPK, AMP-activated protein kinase | MMS, methyl methanesulfonate | CHK, checkpoint kinase | JNK, c-Jun N-terminal kinase | TORC1, mTOR (mammalian target of rapamycin)–raptor (regulatory associated protein of mTOR) complex | BRSK, brain-specific kinase | RIP2, receptor-interacting protein 2 | IGF-1, insulin-like growth factor-1 | S6K1, S6 kinase 1 | DYRK, dual-specificity tyrosine-phosphorylated and -regulated kinase | HIPK, homeodomain-interacting protein kinase | ZMP, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside monophosphate | PRAK, p38-regulated activated kinase | PKC, protein kinase C | Src-I1, Src inhibitor 1 | TANK, TRAF (tumour-necrosis-factor-receptor-associated factor)-family-member-associated nuclear factor κB activator | NFAT, nuclear factor for activated T-cells | PHK, phosphorylase kinase | GSK3, glycogen synthase kinase 3 | PKB, protein kinase B (also called Akt) | CaMK, calmodulin-dependent kinase | CDK, cyclin-dependent protein kinase | NDRG, N-myc downstream-regulated gene | SmMLCK, smooth-muscle myosin light-chain kinase | TBK1, TANK-binding kinase 1 | PRK, protein kinase C-related kinase | SGK, serum- and glucocorticoid-induced kinase
Journal Article
Experimental cell research, ISSN 0014-4827, 03/2017, Volume 352, Issue 2, pp. 403 - 411
Journal Article
Journal Article
Frontiers in oncology, ISSN 2234-943X, 2014, Volume 4, p. 109
The PIM proteins, which were initially discovered as proviral insertion sites in Moloney-murine leukemia virus infection, are a family of highly homologous serine/threonine kinases that have been... 
Transgenics | Proviral tagging | Carcinogens | Knock-out | Pim kinases | Tumors | knock out | tumors | proviral tagging | transgenics
Journal Article
Journal Article
Expert Review of Hematology, ISSN 1747-4086, 02/2012, Volume 5, Issue 1, pp. 81 - 96
Journal Article